Trial · NCT07911163
Clinical Health Outcomes Evaluation of Terumo Aortic Hybrid Devices
NCT07911163, Not yet recruiting, Vascutek Ltd.
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Clinical Health Outcomes Evaluation of Terumo Aortic Hybrid Devices. Trials, record NCT07911163. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07911163
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Clinical Health Outcomes Evaluation of Terumo Aortic Hybrid Devices
- NCT number
- NCT07911163
- Status
- Not yet recruiting
- Enrollment
- 150 participants, estimated
- Lead sponsor
- Vascutek Ltd.
- Conditions
- Aortic Aneurysm and Dissection
- Interventions
- Thoraflex Hybrid
- First posted
- 2026-11-02
- Last updated
- 2026-11-02
Source ClinicalTrials.gov
Registered outcomes28
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Primary Endpoint | 1 year | The primary endpoint is a composite endpoint defined as the absence of the following events through 12-months post-procedure: * All-cause mortality * Aortic rupture in the treated segment * Unanticipated device-related secondary intervention (endovascular or open surgical) |
| Secondary | Individual Components of Primary Endpoint: All-cause mortality | The secondary endpoints will be measured at each standard of care follow-up timepoint from discharge/30 days through to completion of follow up (approx. 10 years). | Rate of all-cause mortality |
| Secondary | Individual Components of Primary Endpoint: Aortic rupture in the treated segment | The secondary endpoints will be measured at each standard of care follow-up timepoint from the procedure/Day 1 through to completion of follow up (approx. 10 years). | Rate of aortic rupture in the treated segment |
| Secondary | Individual Components of Primary Endpoint: Unanticipated device-related secondary intervention (endovascular or open surgical) | The secondary endpoints will be measured at each standard of care follow-up timepoint from the procedure/Day 1 through to completion of follow up (approx. 10 years). | Rate of unanticipated device-related secondary intervention (endovascular or open surgical) |
| Secondary | Major Adverse Events: Stroke | The secondary endpoints will be measured at each standard of care follow-up timepoint from the procedure/Day 1 through to completion of follow up (approx. 10 years). | Rate of Stroke of any type, including transient ischemia attack (TIA) |
| Secondary | Major Adverse Events: Myocardial Infarction (MI) | The secondary endpoints will be measured at each standard of care follow-up timepoint from the procedure/Day 1 through to completion of follow up (approx. 10 years). | Rate of Myocardial Infarction (MI) |
| Secondary | Major Adverse Events: Paraplegia/Paraparesis | The secondary endpoints will be measured at each standard of care follow-up timepoint from the procedure/Day 1 through to completion of follow up (approx. 10 years). | Rate of Paraplegia/Paraparesis |
| Secondary | Major Adverse Events: Respiratory Failure | The secondary endpoints will be measured at each standard of care follow-up timepoint from the procedure/Day 1 through to completion of follow up (approx. 10 years). | Rate of Respiratory Failure |
| Secondary | Major Adverse Events: Renal Failure | The secondary endpoints will be measured at each standard of care follow-up timepoint from the procedure/Day 1 through to completion of follow up (approx. 10 years). | Rate of Renal Failure |
| Secondary | Major Adverse Events: Bowel Ischemia | The secondary endpoints will be measured at each standard of care follow-up timepoint from the procedure/Day 1 through to completion of follow up (approx. 10 years). | Rate of Bowel Ischemia |
1 to 10 of 28Source ClinicalTrials.gov
See all 28 registered outcomesOutcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07911163
GET https://conductscience.org/api/trials/v1/NCT07911163/registered?page=2